Chancroid

Atlas of Sexually Transmitted Diseases and AIDS, Fourth Edition

Volumn , Issue , 2010, Pages 141-156

  Spinola, S ^a,b   Ballard, R ^c  

^a Division of Infectious Diseases   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85172143479     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-4060-3.00008-9     Document Type: Chapter

References (69)

1. PI Bassereau (1852) Traite de affections de la peau symptomatiques de la syphilis. Paris: JB Ballière
2. A Ducrey (1889) Experimentelle Untersuchungen über den Ansteckungsstof des weichen schankers and über die. Bubonen. Montash für Prakt Dermatol 9 387-405.
3. F Bezancon, V Griffon and L Le Sourd (1900) Culture du bacille du chancre mou. CR Soc Biol 11 1048-1051.
4. GW Hammond, CJ Lian, JC Wilt and AR Ronald (1978) Comparison of specimen collection and Laboratory Techniques for Isolation of Haemophilus ducreyi. J Clin Microbiol 7 39-43.
5. CTH Bong, ME Bauer and SM Spinola (2002) Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control. Microb Infect 4 1141-1148.
6. R Steen (2001) Eradicating chancroid. Bull WHO 79 818-826.
7. SM Spinola (2008) Chancroid and Haemophilus ducreyi. KK Holmes, PF Sparling, WE Stamm, et al., (Eds) Sexually Transmitted Diseases 4th ed New York: McGraw-Hill 689-699.
8. FA Plummer, H Nsanze, P Karasira, LJ D’Costa, J Dylewski and AR Ronald (1983) Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet ii 1293-1295.
9. R Steen, B Vuylsteke, T DeCoito, et al. (2000) Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sex Transm Dis 27 1-8.
10. G Paz-Bailey, M Rahman, C Chen, et al. (2005) Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin Infect Dis 41 1304-1312.
11. N O’Farrell, L Morison, P Moodley, et al. (2008) Genital ulcers and concomitant complaints in men attending a sexually transmitted infections clinic: implications for sexually transmitted infections management. Sex Transm Dis 35 545-549.
12. IM Mackay, G Harnett, N Jeoffreys, et al. (2006) Detection and discrimination of Herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clinical Infectious Diseases 42 1431-1438.
13. TR Suntoke, A Hardick, AA Tobian, et al. (2009) Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect 85 97-101.
14. N Rehan (2006) Profile of men suffering from sexually transmitted infections in Pakistan. J Pak Med Assoc 56 S60-S65.
15. R Kaur, N Mittal, P Bhalla, BN Reddy and UK Baveja (2006) Risk factors of herpes simplex virus type 2 among STD clinic attenders in Delhi, India. J Commun Dis 38 339-343.
16. K Ray, M Bala, SM Gupta, et al. (2006) Changing trends in sexually transmitted infections at a Regional STD Centre in north India. Indian J Med Res 124 559-568.
17. N Al-Mutairi, A Joshi, O Nour-Eldin, AK Sharma, I El-Adawy and M Rijhwani (2007) Clinical patterns of sexually transmitted diseases, associated sociodemographic characteristics, and sexual practices in the Farwaniya region of Kuwait. Int J Dermatol 46 594-599.
18. TA Madani (2006) Sexually transmitted infections in Saudi Arabia. BMC Infect Dis 6 3.
19. RP DiCarlo, BA Armentor and DH Martin (1995) Chancroid epidemiology in New Orleans men. J Infect Dis. 172 446-452.
20. CTH Bong, J Harezlak, BP Katz and SM Spinola (2002) Men are more susceptible to pustule formation than women in the experimental model of Haemophilus ducreyi infection. Sex Transm Dis 29 114-118.
21. DM Janowicz, S Ofner, BP Katz and SM Spinola (2009) Experimental infection of human volunteers with Haemophilus ducreyi: 15 years of clinical data and experience. J Infect Dis 199 1671-1679.
22. TL Humphreys, CT Schnizlein-Bick, BP Katz, et al. (2002) Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J Immunol 169 6316-6323.
23. DM Janowicz, K Tenner-Racz, P Racz, et al. (2007) Experimental Infection with Haemophilus ducreyi in Persons Who Are Infected with HIV Does Not Cause Local or Augment Systemic Viral Replication. J Infect Dis 195 1443-1451.
24. SA Morse (1989) Chancroid and Haemophilus ducreyi. Clin Microbiol Rev 2 137-157.
25. JE Ussher, E Wilson, S Campanella, SL Taylor and SA Roberts (2007) Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa. Clin Infect Dis 44 e85-e87.
26. WJ McBride, RC Hannah, GM Le Cornec and C Bletchly (2008) Cutaneous chancroid in a visitor from Vanuatu. Australas J Dermatol 49 98-99.
27. R King, J Gough, A Ronald, et al. (1996) An immunohistochemical analysis of naturally occurring chancroid. J Infect Dis 174 427-430.
28. CM Magro, AN Crowson, M Alfa, et al. (1996) A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Human Pathology 27 1066-1070.
29. R King, SH Choudhri, J Nasio, et al. (1998) Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection. Int J STD AIDS 9 531-536.
30. ME Bauer, MP Goheen, CA Townsend and SM Spinola (2001) Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect Immun 69 2549-2557.
31. ME Bauer and SM Spinola (2000) Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection. Infect Immun 68 2309-2314.
32. TL Humphreys, LA Baldridge, SD Billings, JJ Campbell and SM Spinola (2005) Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi. Infect Immun 73 3896-3902.
33. W Li, DM Janowicz, KR Fortney, BP Katz and SM Spinola (2009) Mechanism of human natural killer cell activation by Haemophilus ducreyi. J Infect Dis 200 590-598.
34. KE Banks, T Humphreys, W Li, BP Katz, DS Wilkes and SM Spinola (2007) Haemophilus ducreyi partially activates human myeloid dendritic cells. Infect Immun 75 5678-5685.
35. V Gelfanova, TL Humphreys and SM Spinola (2001) Characterization of Haemophilus ducreyi-specific T cell lines from lesions of experimentally infected human subjects. Infect Immun 69 4224-4231.
36. ME Bauer, CA Townsend, AR Ronald and SM Spinola (2006) Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbe Infect 8 2465-2468.
37. T Humphreys, L Li, X Li, et al. (2007) Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers. Infect Immun 75 5686-5697.
38. SM Spinola, CTH Bong, AL Faber, et al. (2003) Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection. Infect Immun 71 6658-6663.
39. M Labandeira-Rey, DM Janowicz, RJ Blick, et al. (2009) Inactivation of the Haemophilus ducreyi luxS gene affects the virulence of this pathogen in human subjects. J Infect Dis 200 409-416.
40. H Christensen, P Kuhnert, JE Olsen and M Bisgaard (2004) Comparative phylogenies of the housekeeping genes atpD, infB and rpoB and the 16S rRNA gene within the Pasteurellaceae. International Journal of Systematic & Evolutionary. Microbiology 54 1601-1609.
41. J Gioia, X Qin, H Jiang, et al. (2006) The genome sequence of Mannheimia haemolytica A1: insights into virulence, natural competence, and Pasteurellaceae phylogeny. Journal of Bacteriology 188 7257-7266.
42. CD White, I Leduc, C Jeter, C Harris and C Elkins (2005) Haemophilus ducreyi outer membrane determinants, including DsrA, define two clonal populations. Infect Immun 73 2387-2399.
43. NK Scheffler, AM Falick, SC Hall, et al. (2003) Proteome of Haemophilus ducreyi by 2-D SDS-page and mass spectrometry: strain variation, virulence, and carbohydrate expression. J Proteome Res 2 523-533.
44. DMB Post, RS Munson Jr, B Baker, H Zhong, JA Bozue and BW Gibson (2007) Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi. Infect Immun 75 113-121.
45. DA Lewis (2000) Diagnostic tests for chancroid. Sex Transm Infect 76 137-141.
46. Y Dangor, F Radebe and R Ballard (1993) Transport media for Haemophilus ducreyi. Sex Transm Dis 20 5-9.
47. KA Orle, CA Gates, DH Martin, BA Body and JB Weiss (1996) Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and Herpes Simplex Virus types 1 and 2 from genital ulcers. J Clin Microbiol 34 49-54.
48. SA Morse, DL Trees, Y Htun, et al. (1997) Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 175 583-589.
49. G Schmid, Y Faur, J Valu, S Sikandar and M McLaughlin (1995) Enhanced recovery of Haemophilus ducreyi from clinical specimens by incubation at 33 versus 35 oC. J. Clin. Microbiol. 33 3257-3259.
50. A Pillay, A Hoosen, D Loykissoonlal, C Glock, B Odhav and AW Sturm (1998) Comparison of culture media for the laboratory diagnosis of chancroid. J Med Microbiol 47 1023-1026.
51. DL Trees and SA Morse (1995) Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev 8 357-375.
52. AK Haydock, DH Martin, SA Morse, C Cammarata, KJ Mertz and PA Totten (1999) Molecular characterization of Haemophilus ducreyi strains from Jackson, Mississippi, and New Orleans, Louisiana. J Infect Dis 179 1423-1432.
53. CY Chen, KJ Mertz, SM Spinola and SA Morse (1997) Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States. J Infect Dis 175 1390-1395.
54. C Elkins, K Yi, B Olsen, C Thomas, K Thomas and S Morse (2000) Development of a serological test for Haemophilus ducreyi for seroprevalence studies. J Clin Microbiol 38 1520-1526.
55. AM Nicasio, JL Kuti and DP Nicolau (2008) The current state of multidrug-resistant gram-negative bacilli in North America. Pharmacotherapy 28 235-249.
56. T Lagergard, A Frisk and B Trollfors (1996) Comparison of the E-test with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi. J Antimicrob Chemother 38 849-852.
57. AR Ronald, L Corey, JA McCutchan and HH Handsfield (1992) Evaluation of new anti-infective drugs for the treatment of chancroid. Clin Infect Dis 15 S108-S114.
58. MW Tyndall, E Agoki, FA Plummer, W Malisa, JO Ndinya-Achola and AR Ronald (1994) Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 21 231-234.
59. Y Dangor, RC Ballard, SD Miller and HJ Koornhof (1990) Treatment of chancroid. Antimicrob Agents Chemother 34 1308-1311.
60. A Ernst, E Marvez-Valls and D Martin (1995) Incision and drainage versus aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. Sex Transm Dis 217-220.
61. Centers for Disease Control and Prevention (2006) Sexually transmitted diseases treatment guidelines 2006. MMWR 55 1-94.
62. World Health Organization 2001 Guidelines for the management of sexually transmitted infections. Http://www.who.int/HIV_AIDS/
63. Clinical Effectiveness Group (1999) National guideline for the management of chancroid. Sex Transm Inf 75(Suppl 1), S43-S45.
64. AC Thornton, EM O’Mara Jr, SJ Sorensen, et al. (1998) Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial. J Infect Dis 177 1608-1613.
65. M Tyndall, M Malisa, FA Plummer, J Ombetti, JO Ndinya-Achola and AR. Ronald (1993) Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 167 469-471.
66. RC Ballard, H Ye, A Matta, Y Dangor and F Radebe (1996) Treatment of chancroid with azithromycin. Int J STD AIDS 7(Suppl. 1), 9-12.
67. J Bogaerts, L Kestens, WM Tello, et al. (1995) Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole. Clin Infect Dis 20 924-930.
68. IM Malonza, MW Tyndall, JO Ndinya-Achola, et al. (1999) A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J Infect Dis 180 1886-1893.
69. C Hoyo, I Hoffman, BK Moser, et al. (2005) Improving the accuracy of syndromic diagnosis of genital ulcer disease in Malawi. Sex Transm Dis 32 231-237.